None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients with fibromyalgia(M79.7) registered as the main diagnosis - Patients who satisfy 'Widespread pain index(WPI) = 7 and symptom severity scale (SSS) score = 5' or 'WPI 4-6 and SSS score = 9' in the modified 2016 ACR criteria for fibromyalgia. - Patients who have had general pain(at least 4-5 sites) for more than 3 months. - Patients over the age of 19 who voluntarily deciede to participate in this clinical study and signed the consent form.
Exclusion criteria
Exclusion criteria: - Patients participating in other clinical studies. - Patients receiving Korean medicine treatment through other clinics for the purpose of treating fibromyalgia. - Patients who are expected to have difficulty complying with the clinical study schedule. - Patients who are expected to have difficulties in understanding and responding to research questionnaires such as illiteracy and mental and physical weakness. - Patients judged to be difficult to participate in clinical reseach based on the opinion of the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numeric rating scale(NRS) (average and most severe pain of the day) | — |
Secondary
| Measure | Time frame |
|---|---|
| Revised Fibromyalgia Impact Questionnaire(FIQR), Pain Catastrophizing Scale(PCS), Pain Pressure Threshold(PPT);Beck Depression Inventory(BDI-?), Beck Anxiety inventory(BAI);Emotional response test, Empathy Quotient, Social network survey;Daily Sleep Interference Scale(DSIS), Fatigue Severity Scale(FSS), EuroQol Five dimension scale(EA-5D-5L);Patients’ Global Impression of Change(PGIC) | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Oriental Medical Center